“…[1][2][3] Accordingly, over the last two decades, there has been an increasing interest worldwide about the identification of tumor markers useful for both diagnostic and therapeutic purposes in pediatric oncology. [4][5][6][7][8][9][10][11][12][13][14] Apart from neuroblastoma, hepatoblastoma, and germ cell tumors, the majority of solid pediatric tumors have no tumor-specific markers detectable in the serum of patients.…”